Preclinical Imaging Market 2025 to 2034
Preclinical Imaging Market 2025 to 2034
Preclinical Imaging Market (By Product: CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents, Services; By End-User: Biotech Companies, Pharmaceutical Companies, Research Institutes; By Region: North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 3.05 Bn
Forecast Year, 2034
USD 4.45 Bn
CAGR, 2025 - 2034
4.30%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The preclinical imaging market, valued at USD 3.05 billion in 2025, is expected to grow to USD 4.45 billion by 2034, reflecting a CAGR of 4.30%. This growth is driven by advancements in imaging technologies and their crucial role in drug development and disease research.
Preclinical Imaging Market Size Analysis
Preclinical Imaging Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| CT Imaging | 0.28 | 0.29 | 0.31 | 0.32 | 0.33 | 0.35 | 0.36 | 0.38 | 0.39 | 0.41 |
| MRI Imaging | 0.30 | 0.31 | 0.32 | 0.34 | 0.35 | 0.37 | 0.38 | 0.40 | 0.41 | 0.43 |
| PET/SPECT Imaging | 0.31 | 0.32 | 0.34 | 0.35 | 0.37 | 0.38 | 0.40 | 0.42 | 0.43 | 0.45 |
| Multi-modal Imaging | 0.33 | 0.34 | 0.35 | 0.37 | 0.38 | 0.40 | 0.42 | 0.44 | 0.45 | 0.47 |
| Optical Imaging | 0.34 | 0.35 | 0.37 | 0.39 | 0.40 | 0.42 | 0.44 | 0.46 | 0.47 | 0.49 |
| Ultrasound Imaging | 0.35 | 0.37 | 0.38 | 0.40 | 0.42 | 0.44 | 0.46 | 0.47 | 0.50 | 0.52 |
| Photoacoustic Imaging | 0.37 | 0.38 | 0.40 | 0.42 | 0.44 | 0.45 | 0.47 | 0.49 | 0.52 | 0.54 |
| Reagents | 0.38 | 0.40 | 0.41 | 0.43 | 0.45 | 0.47 | 0.49 | 0.51 | 0.54 | 0.56 |
| Services | 0.40 | 0.41 | 0.43 | 0.45 | 0.47 | 0.49 | 0.51 | 0.53 | 0.56 | 0.58 |
Preclinical Imaging Market Size By End-User 2025 to 2034 (USD Billion)
| End-User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Biotech Companies | 0.97 | 1.01 | 1.04 | 1.09 | 1.13 | 1.17 | 1.22 | 1.27 | 1.32 | 1.37 |
| Pharmaceutical Companies | 1.02 | 1.06 | 1.11 | 1.15 | 1.20 | 1.26 | 1.31 | 1.37 | 1.42 | 1.48 |
| Research Institutes | 1.07 | 1.12 | 1.17 | 1.22 | 1.28 | 1.34 | 1.40 | 1.46 | 1.53 | 1.60 |
Preclinical Imaging Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.56 | 0.58 | 0.60 | 0.62 | 0.65 | 0.68 | 0.70 | 0.73 | 0.76 | 0.79 |
| Europe | 0.58 | 0.61 | 0.63 | 0.66 | 0.68 | 0.71 | 0.74 | 0.77 | 0.81 | 0.84 |
| Asia Pacific | 0.61 | 0.64 | 0.66 | 0.69 | 0.72 | 0.75 | 0.79 | 0.82 | 0.85 | 0.89 |
| Latin America | 0.64 | 0.67 | 0.70 | 0.73 | 0.76 | 0.79 | 0.83 | 0.86 | 0.90 | 0.94 |
| Middle East and Africa | 0.67 | 0.70 | 0.73 | 0.76 | 0.80 | 0.83 | 0.87 | 0.91 | 0.95 | 0.99 |
Preclinical Imaging Market Size to Reach USD 4.45 Billion by 2034
The preclinical imaging market size accounted for USD 3.05 billion in 2025 and is predicted to touch around USD 4.45 billion by 2034 at a CAGR of 4.30%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
